Igc Pharma Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Igc Pharma Inc inventory turnover ratio, the Igc Pharma Inc 's ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 0.9 in the second quarter 2026, yet the ratio remained below the average, as IGC's market remain challenging.Average inventory processing period, for the Igc Pharma Inc in Jun 30 2026 quarter, has decreased to 406 days, compare to 521 days, in the Mar 31 2026 quarter.

Within Healthcare sector 324 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1581 in the first quarter 2026, to 1862.

IGC Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Igc Pharma Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

IGC Inventory Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Sep 30 2025) II. Quarter	(Jun 30 2025) I. Quarter	(Mar 31 2025) IV. Quarter
Y / Y Inventory Growth	-52.56 %	-53.09 %	-11.69 %	-56.42 %	-10.66 %
Y / Y Cost of Sales Growth	23.3 %	71.24 %	-57.01 %	59.63 %	41.94 %
Inventory Turnover Ratio (TTM)	0.9	0.7	0.5	0.58	0.45
IGC's Total Ranking	# 1862	# 1581	# 1634	# 1681	#
Average inventory processing period	404	519	725	624	806
Seq. Inventory Growth	0.31 %	-53.09 %	106.69 %	-51.22 %	-0.81 %
Seq. Cost of Sales Growth	-17.18 %	184.78 %	-47.13 %	-1.14 %	15.03 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 98
Healthcare Sector	# 325
Overall Market	# 1862

Inventory Turnover Ratio Statistics
High	Average	Low
15.88	4.85	0.04
(Jun 30 2013)		(Dec 31 2021)

IGC Company Profile >> Back to IGC Efficiency Comparisons >> Compare IGC Inventory Turnover Ratio to its Competitors

Financial Statements
Igc Pharma Inc 's Inventories	$ 1 Millions	Visit IGC's Balance sheet
Igc Pharma Inc 's Cost of Revenues TTM	$ 1 Millions	Visit IGC's Income Statement
What are IGC's Sales?		Visit IGC's Sales by Segment

Other Inventory Turnover Ratios
Igc Pharma Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
IGC's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for IGC's Competitors
Inventory Turnover Ratio for IGC's Suppliers
Inventory Turnover Ratio for IGC's Customers

You may also want to know
IGC's Sales Growth Rates	IGC's Pe Price to earnings ratio	IGC's Receivables Turnover Ratio	IGC's Stock Quote
IGC's Net Income Growth Rates	IGC's Ps Price to Sales ratio	IGC's Sales per Employee	IGC's Asset Turnover Ratio
IGC's Net Margin	IGC's Pb Price to Book ratio	IGC's Financial Strength Ratios	IGC's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Jun 30 2026	Inventories at quarter ending Jun 30 2026
Agilent Technologies inc	3.20	$ 3,404.000 Millions	$ 1,064 Millions
Mettler toledo International Inc	3.18	$ 1,277.460 Millions	$ 401 Millions
Bionexus Gene Lab Corp	3.15	$ 2.362 Millions	$ 1 Millions
Eton Pharmaceuticals Inc	3.11	$ 44.176 Millions	$ 14 Millions
Mimedx Group Inc	3.07	$ 75.981 Millions	$ 25 Millions
Resmed Inc	2.97	$ 2,770.562 Millions	$ 933 Millions
Msa Safety Inc	2.92	$ 1,021.036 Millions	$ 350 Millions
Ligand Pharmaceuticals Incorporated	2.91	$ 32.387 Millions	$ 11 Millions
Logicmark Inc	2.83	$ 3.881 Millions	$ 1 Millions
Merck and Co Inc	2.79	$ 17,996.000 Millions	$ 6,447 Millions
Inspiremd Inc	2.78	$ 8.847 Millions	$ 3 Millions
Ani Pharmaceuticals Inc	2.69	$ 387.398 Millions	$ 144 Millions
International Stem Cell Corporation	2.61	$ 4.285 Millions	$ 2 Millions
Biomerica Inc	2.59	$ 4.091 Millions	$ 2 Millions
Evofem Biosciences Inc	2.58	$ 4.418 Millions	$ 2 Millions
Nephros Inc	2.54	$ 8.991 Millions	$ 4 Millions
Illumina Inc	2.52	$ 1,510.000 Millions	$ 599 Millions
IMPACT BIOMEDICAL INC.	2.46	$ 0.414 Millions	$ 0 Millions
Quidelortho Corp	2.45	$ 1,481.500 Millions	$ 605 Millions
Pro dex Inc	2.43	$ 53.213 Millions	$ 22 Millions
Angiodynamics Inc	2.43	$ 142.834 Millions	$ 59 Millions
Journey Medical Corp	2.42	$ 23.556 Millions	$ 10 Millions
Aquestive Therapeutics Inc	2.42	$ 17.828 Millions	$ 7 Millions
Cannapharmarx Inc	2.37	$ 2.483 Millions	$ 1 Millions
Fortress Biotech Inc	2.34	$ 22.768 Millions	$ 10 Millions
Scientific Industries Inc	2.33	$ 4.057 Millions	$ 2 Millions
Insight Molecular Diagnostics Inc	2.31	$ 0.868 Millions	$ 0 Millions
Sanara Medtech Inc	2.29	$ 7.981 Millions	$ 3 Millions
China Pharma Holdings Inc	2.25	$ 3.450 Millions	$ 2 Millions
Beta Bionics Inc	2.23	$ 50.111 Millions	$ 22 Millions

Date modified: 2026-08-16T08:24:24+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.